LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 13.87 | 27.76 | 1099 | 604 | 1.8174 | 1.2877 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 15.58 | 27.76 | 3 | 685 | 0.0044 | -0.3818 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 15.58 | 27.76 | 844 | 685 | 1.2311 | 1.0919 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 15.58 | 27.76 | 34 | 685 | 0.0496 | 0.0448 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 15.58 | 27.76 | 1127 | 685 | 1.6439 | 1.2269 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.28 | 27.76 | 7 | 838 | 0.0083 | -0.2443 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.28 | 27.76 | 853 | 838 | 1.0170 | 1.0069 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.28 | 27.76 | 27 | 838 | 0.0322 | -0.0056 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 17.28 | 27.76 | 1120 | 838 | 1.3354 | 1.1212 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.98 | 27.76 | 8 | 941 | 0.0085 | -0.2171 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.98 | 27.76 | 867 | 941 | 0.9212 | 0.9680 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.98 | 27.76 | 40 | 941 | 0.0425 | 0.0745 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 18.98 | 27.76 | 1154 | 941 | 1.2262 | 1.0819 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.68 | 27.76 | 14 | 1119 | 0.0125 | -0.1205 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.68 | 27.76 | 888 | 1119 | 0.7936 | 0.9151 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.68 | 27.76 | 61 | 1119 | 0.0545 | 0.1591 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 20.68 | 27.76 | 1169 | 1119 | 1.0447 | 1.0165 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.39 | 27.76 | 16 | 1305 | 0.0123 | -0.0944 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.39 | 27.76 | 899 | 1305 | 0.6885 | 0.8701 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.39 | 27.76 | 64 | 1305 | 0.0490 | 0.1623 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 22.39 | 27.76 | 1202 | 1305 | 0.9206 | 0.9704 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.09 | 27.76 | 18 | 1461 | 0.0123 | -0.0730 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.09 | 27.76 | 939 | 1461 | 0.6424 | 0.8511 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.09 | 27.76 | 67 | 1461 | 0.0458 | 0.1666 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 24.09 | 27.76 | 1197 | 1461 | 0.8189 | 0.9314 | MN20160318_Q01 | L17 |